BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...Driehaus Capital Management and ArrowMark Partners, plus existing investors Sands Capital, Longwood Fund, PBM Capital, Boulder Ventures...
BioCentury | May 15, 2019
Financial News

May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen

...diagnostic program and expand its liquid biopsy-based minimal residual disease platform. Existing investors PBM Capital, Boulder Ventures...
BioCentury | Feb 17, 2017
Financial News

Miragen completes venture financing

...to form Miragen Therapeutics Inc. (NASDAQ:MGEN). Investors included Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 3, 2016
Company News

Signal, miRagen deal

...prior to the merger's close. The syndicate includes Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 1, 2016
Company News

miRagen finds public path via Signal merger

...prior to the merger's close. The syndicate includes Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 16, 2015
Financial News

miRagen completes venture financing

...Research Labs Ventures Fund; JAFCO; Brace Pharma Capital; MP Healthcare Venture Management Inc.; Atlas Venture; Boulder Ventures...
BioCentury | Nov 11, 2015
Financial News

miRagen raises $41 series C

...new investors Brace Pharma Capital and MP Healthcare Venture Management joined existing investors Atlas Venture, Boulder Ventures...
BioCentury | Jan 6, 2014
Financial News

Boulder Ventures Ltd. financial update

...VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according...
...company miRagen Therapeutics Inc. (Boulder, Colo.) and cancer play Array BioPharma Inc. (NASDAQ:ARRY, Boulder, Colo.). Boulder Ventures Ltd....
BioCentury | Dec 27, 2013
Financial News

Boulder Ventures raising $100 million for sixth fund

...VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according...
...include microRNA company miRagen Therapeutics Inc. (Boulder, Colo.) and cancer play Array BioPharma Inc. (NASDAQ:ARRY). Boulder Ventures...
BioCentury | Apr 30, 2012
Financial News

miRagen completes venture financing

...Cardiovascular Date completed: 4/24/12 Type: Venture financing Raised: $20 million Investors: Remeditex Ventures; Atlas Venture; Boulder Ventures...
Items per page:
1 - 10 of 27
BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...Driehaus Capital Management and ArrowMark Partners, plus existing investors Sands Capital, Longwood Fund, PBM Capital, Boulder Ventures...
BioCentury | May 15, 2019
Financial News

May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen

...diagnostic program and expand its liquid biopsy-based minimal residual disease platform. Existing investors PBM Capital, Boulder Ventures...
BioCentury | Feb 17, 2017
Financial News

Miragen completes venture financing

...to form Miragen Therapeutics Inc. (NASDAQ:MGEN). Investors included Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 3, 2016
Company News

Signal, miRagen deal

...prior to the merger's close. The syndicate includes Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 1, 2016
Company News

miRagen finds public path via Signal merger

...prior to the merger's close. The syndicate includes Fidelity, Brace Pharma Capital, Atlas Venture , Boulder Ventures...
BioCentury | Nov 16, 2015
Financial News

miRagen completes venture financing

...Research Labs Ventures Fund; JAFCO; Brace Pharma Capital; MP Healthcare Venture Management Inc.; Atlas Venture; Boulder Ventures...
BioCentury | Nov 11, 2015
Financial News

miRagen raises $41 series C

...new investors Brace Pharma Capital and MP Healthcare Venture Management joined existing investors Atlas Venture, Boulder Ventures...
BioCentury | Jan 6, 2014
Financial News

Boulder Ventures Ltd. financial update

...VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according...
...company miRagen Therapeutics Inc. (Boulder, Colo.) and cancer play Array BioPharma Inc. (NASDAQ:ARRY, Boulder, Colo.). Boulder Ventures Ltd....
BioCentury | Dec 27, 2013
Financial News

Boulder Ventures raising $100 million for sixth fund

...VC firm Boulder Ventures is aiming to raise up to $100 million for its sixth fund, according...
...include microRNA company miRagen Therapeutics Inc. (Boulder, Colo.) and cancer play Array BioPharma Inc. (NASDAQ:ARRY). Boulder Ventures...
BioCentury | Apr 30, 2012
Financial News

miRagen completes venture financing

...Cardiovascular Date completed: 4/24/12 Type: Venture financing Raised: $20 million Investors: Remeditex Ventures; Atlas Venture; Boulder Ventures...
Items per page:
1 - 10 of 27